Variant report

Variant	esv3347085
Chromosome Location	chr21:46320424-46323822
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:16)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr21:46274218..46276249-chr21:46318911..46322162,3	K562	blood:
2	chr21:46291242..46294677-chr21:46316286..46321756,7	MCF-7	breast:
3	chr21:46291446..46293976-chr21:46322203..46327064,4	MCF-7	breast:
4	chr21:46318143..46320481-chr21:46398627..46400161,2	MCF-7	breast:
5	chr21:46322975..46323793-chr21:46347666..46348173,2	MCF-7	breast:
6	chr21:46323100..46323793-chr21:46347666..46348595,2	MCF-7	breast:
7	chr21:46256501..46258560-chr21:46321252..46323907,2	MCF-7	breast:
8	chr21:46236410..46239097-chr21:46320402..46324022,3	MCF-7	breast:
9	chr21:46273736..46276118-chr21:46318911..46321245,2	K562	blood:
10	chr21:46222418..46224515-chr21:46321449..46323045,2	MCF-7	breast:
11	chr21:46316977..46318505-chr21:46320167..46321939,2	K562	blood:
12	chr21:46302796..46304799-chr21:46319469..46322179,2	MCF-7	breast:
13	chr21:46320135..46322797-chr21:46323413..46327575,5	K562	blood:
14	chr21:46314850..46316608-chr21:46322131..46323890,2	K562	blood:
15	chr21:46320135..46322797-chr21:46323413..46327575,5	K562	blood:
16	chr21:46319170..46322090-chr21:46324172..46325775,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000184900	chromatin interactions
ENSG00000236519	chromatin interactions
ENSG00000183255	chromatin interactions

Extended variants
information (count: 256 )
Associated
traits (count: 96 )

Variant overlapped rSNPs/rCNVs (count:256 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs533183525	chr21:46320443-46320444	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs551566893	chr21:46320444-46320445	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs36082126	chr21:46320488-46320489	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs537169492	chr21:46320501-46320502	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs549097231	chr21:46320509-46320510	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs567294969	chr21:46320543-46320544	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs534282669	chr21:46320550-46320551	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs149115165	chr21:46320553-46320554	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs79643064	chr21:46320556-46320557	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs112932766	chr21:46320558-46320559	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs61264894	chr21:46320587-46320588	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs571822403	chr21:46320588-46320589	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs538864433	chr21:46320594-46320595	Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs377510871	chr21:46320602-46320603	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs557168837	chr21:46320620-46320621	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs575412647	chr21:46320651-46320652	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs370657844	chr21:46320683-46320684	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs554606033	chr21:46320688-46320689	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs568921090	chr21:46320705-46320706	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs535934255	chr21:46320710-46320711	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs79249663	chr21:46320721-46320722	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs143322843	chr21:46320722-46320723	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs112240820	chr21:46320742-46320743	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs369593091	chr21:46320743-46320744	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs545300395	chr21:46320799-46320800	Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs147133583	chr21:46320800-46320801	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs572705685	chr21:46320805-46320806	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs530716111	chr21:46320806-46320807	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs549072095	chr21:46320817-46320818	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs140328608	chr21:46320827-46320828	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs375025770	chr21:46320829-46320830	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs186881299	chr21:46320830-46320831	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs570896531	chr21:46320834-46320835	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs2329940	chr21:46320849-46320850	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs374680873	chr21:46320853-46320854	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs149264896	chr21:46320857-46320858	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs190521776	chr21:46320876-46320877	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs530321308	chr21:46320877-46320878	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs117031423	chr21:46320888-46320889	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs77773920	chr21:46320889-46320890	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs376999738	chr21:46320995-46320996	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs558708753	chr21:46321000-46321001	Weak transcription Bivalent Enhancer Genic enhancers Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs73239719	chr21:46321001-46321002	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs545595232	chr21:46321006-46321007	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs563534556	chr21:46321015-46321016	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs371608028	chr21:46321027-46321028	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs760464	chr21:46321035-46321036	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs183408386	chr21:46321036-46321037	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs561057330	chr21:46321043-46321044	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs528210634	chr21:46321045-46321046	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:96)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	17426248	CNVD
Developmental delay	21147756	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:157 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:46295600-46338800	Weak transcription	Right Atrium	heart
2	chr21:46298400-46326600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
3	chr21:46305400-46322400	Strong transcription	Dnd41	blood
4	chr21:46305400-46325000	Strong transcription	Primary T regulatory cells fromperipheralblood	blood
5	chr21:46313800-46324800	Strong transcription	Primary T helper naive cells fromperipheralblood	blood
6	chr21:46313800-46326600	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
7	chr21:46313800-46326800	Strong transcription	Fetal Thymus	thymus
8	chr21:46314200-46323000	Strong transcription	Thymus	Thymus
9	chr21:46314400-46322200	Strong transcription	Primary neutrophils fromperipheralblood	blood
10	chr21:46314400-46330200	Strong transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
11	chr21:46314600-46324800	Strong transcription	Primary T helper cells fromperipheralblood	blood
12	chr21:46314800-46321800	Weak transcription	Rectal Smooth Muscle	rectum
13	chr21:46315000-46321600	Weak transcription	Liver	Liver
14	chr21:46315200-46321800	Weak transcription	Duodenum Smooth Muscle	Duodenum
15	chr21:46315800-46322400	Strong transcription	Primary hematopoietic stem cells short term culture	blood
16	chr21:46316000-46324400	Weak transcription	H9 Cell Line	embryonic stem cell
17	chr21:46316400-46324000	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr21:46316600-46327200	Strong transcription	Primary T cells from cord blood	blood
19	chr21:46317200-46324800	Strong transcription	Primary T killer memory cells from peripheral blood	blood
20	chr21:46317600-46324200	Strong transcription	Primary T helper naive cells from peripheral blood	blood
21	chr21:46317800-46324200	Strong transcription	Primary T killer naive cells fromperipheralblood	blood
22	chr21:46317800-46325400	Strong transcription	Primary mononuclear cells fromperipheralblood	Blood
23	chr21:46318000-46320800	Weak transcription	Esophagus	oesophagus
24	chr21:46318000-46321600	Genic enhancers	Primary T cells fromperipheralblood	blood
25	chr21:46318000-46321800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
26	chr21:46318200-46320600	Strong transcription	Lung	lung
27	chr21:46318200-46321400	Weak transcription	Sigmoid Colon	Sigmoid Colon
28	chr21:46318200-46321800	Weak transcription	Rectal Mucosa Donor 31	rectum
29	chr21:46318200-46321800	Weak transcription	HepG2	liver
30	chr21:46318200-46325000	Strong transcription	Primary B cells from peripheral blood	blood
31	chr21:46318200-46327200	Strong transcription	Primary T helper 17 cells PMA-I stimulated	--
32	chr21:46318400-46320800	Weak transcription	GM12878-XiMat	blood
33	chr21:46318400-46325000	Strong transcription	Primary T helper memory cells from peripheral blood 2	blood
34	chr21:46318400-46325000	Strong transcription	Primary Natural Killer cells fromperipheralblood	blood
35	chr21:46318600-46324600	Strong transcription	Primary T helper cells PMA-I stimulated	--
36	chr21:46318800-46321800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
37	chr21:46318800-46322800	Strong transcription	Rectal Mucosa Donor 29	rectum
38	chr21:46319400-46320800	Weak transcription	Gastric	stomach
39	chr21:46319400-46321400	Strong transcription	Monocytes-CD14+_RO01746	blood
40	chr21:46319400-46322000	Strong transcription	Primary monocytes fromperipheralblood	blood
41	chr21:46319400-46325800	Weak transcription	Fetal Intestine Small	intestine
42	chr21:46319600-46326800	Genic enhancers	Spleen	Spleen
43	chr21:46319800-46321200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr21:46320000-46323400	Strong transcription	Primary B cells from cord blood	blood
45	chr21:46320000-46326200	Weak transcription	Fetal Muscle Leg	muscle
46	chr21:46320000-46331000	Weak transcription	Brain Substantia Nigra	brain
47	chr21:46320200-46322000	Weak transcription	HSMMtube	muscle
48	chr21:46320200-46322200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
49	chr21:46320400-46320600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
50	chr21:46320400-46320800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links